PubHealth.infoŽ (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.infoŽ, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.infoŽ presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.infoŽ regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.infoŽ is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.infoŽ (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 31: Articles 15001-15500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Programmatic and non-programmatic determinants of contraceptive prevalence levels in rural Bangladesh.
  2. Programmatic factors in contraceptive use-effectiveness: lessons learned from operations research.
  3. Programmed oocyte retrieval: clinical and biological effects of oral contraceptives administered before in vitro fertilization.
  4. Progress in combined oral contraception: gestodene, third generation progestogen. [Un progres dans la contraception orale combinee : le gestodene, progestatif de troisieme generation.]
  5. Prolonged or early use of oral contraceptives -- which one is the greatest risk for the development of breast cancer? [Langtidsbruk eller tidig anvandning av p-piller -- vilket har storst samband med brostcancerrisken?]
  6. Prolonged use of medroxyprogesterone acetate (MPA) as a contraceptive. [Uso prolongado do acetato de medroxiprogesterona (AMP) como anticoncepcional.]
  7. Promoting condoms for AIDS prevention: ten lessons learned from family planning programs.
  8. Promoting family planning for better health: policy and programme implications.
  9. Promoting family planning information, education and communication in Sub-Saharan Africa: recent experiences of anglophone family planning associations (being proceedings of an IEC Strategy Planning Workshop held in Mauritius, 15-19 August, 1988)
  10. Promoting maternal health through family planning in Nigeria.
  11. Proposal for new contraception legislation in Chad. [Project to change law no. 28 issued December 29, 1965 on the organization of the pharmacy. [Projet de decret protant application de la loi No. 28 du 29 Decembre 1965 organisant l'exercise de la pharmacie.]
  12. Proposal of the guidelines for the implementation of family planning services in health care.
  13. A prospective New Zealand study of fertility after removal of copper intrauterine contraceptive devices for conception and because of complications: a four-year study.
  14. Prospective study of oral contraceptive use and risk of breast cancer in women.
  15. The protective effect of the oral contraceptive pill on rheumatoid arthritis: an overview of the analytical epidemiological studies using meta-analysis.
  16. Protex condoms. Development of the Moroccan Contraceptive Social Marketing Project.
  17. Providing prenatal care services at family planning clinics: problems and opportunities.
  18. Psychosocial aspects of contraceptive method choice.
  19. Psychosocial consequences to women of contraceptive use and controlled fertility.
  20. Psychosocial consequences to women of contraceptive use and controlled fertility.
  21. Psychosocial factors in contraceptive efficacy.
  22. Public / private sector joint partnership achieving social goals: the Indonesian family planning experience.
  23. Quality in family planning information and in family planning service delivery. [Calidad en la informacion y en la entrega de servicios de planificacion familiar.]
  24. Quality of care in family planning services in rural China.
  25. Quality of knowledge and use of contraceptive methods in Atlantic coast Colombia. [Calidad del conocimiento y uso de metodos anticonceptivos en la Costa Atlantica Colombiana.]
  26. Quantitation of plasma levels of tetranectin -- effects of oral contraceptives, pregnancy, treatment with L-asparaginase and liver cirrhosis.
  27. Quantitative supervision in family planning. [La supervision quantitative en planification familiale.]
  28. Re: "Breast Cancer Before Age 45 and Oral Contraceptive Use: New Findings" [letter]
  29. Re: "Breast Cancer Before Age 45 and Oral Contraceptive Use: New Findings" [letter]
  30. Re: "Breast Cancer Before Age 45 and Oral Contraceptive Use: New Findings" [letter]
  31. Re: "Breast Cancer Before Age 45 And Oral Contraceptive Use: New Findings", the authors reply [letter]
  32. Re: "Potential for Bias in Case-Control Studies of Oral Contraceptives and Breast Cancer" [letter]
  33. Re: "Potential for Bias in Case-Control Studies of Oral Contraceptives and Breast Cancer". The author replies [letter]
  34. The reach and effectiveness of media used for popularising the family planning programme.
  35. Reasons for non-use of family planning methods at Ilorin, Nigeria: male opposition and fear of methods.
  36. Recent decline in birth rate in India and its relationship with contraceptive prevalence.
  37. Recent developments in contraceptive technology: risks and benefits.
  38. Recent trends in contraceptive sterilization in Flanders.
  39. Reclassification of contraceptives.
  40. Reconciliation of family planning evaluation and fertility trend with special reference to Kerala.
  41. Rectal perforation by an intrauterine contraceptive device presenting in advanced pregnancy.
  42. Registration, information and evaluation system of the extension process of training in reproductive risk and family planning. [Sistema de registro, informacion y evaluacion del proceso de extension de la capacitacion sobre riesgo reproductivo y planificacion familiar.]
  43. The relationship between local family planning expenditures and fertility in Thailand, 1976-1981.
  44. The relevance of the pharmacologic properties of a progestational agent to its clinical effects as a combination oral contraceptive.
  45. Renal vein thrombosis in a dehydrated patient on an oral contraceptive agent.
  46. Report of the International Training Workshops on Family Planning Policy and Program Management, 1987 and 1988.
  47. Report on the Survey of Family Planning Knowledge, Attitude and Practice in Hong Kong, 1987.
  48. Reproductive tract infections in a family planning population in rural Bangladesh.
  49. A research on the assurance of family planning and providing for the aged.
  50. Residual function in the ovary during low-dose oral contraceptive treatment. [Residualfunktionen i ovariet ved lavdoseret p-pillebehandling.]
  51. Resource mobilization, logistics and financial management for South Asian family planning associations. Report of a workshop.
  52. Responding to change: factors associated with state family planning expenditures.
  53. Results of an inquiry: the preventive aspect of sexual transmission is an important part of the work of family planning departments. [Enkat visar: smittskyddsaspekten viktig vid preventivmedelsradgivning.]
  54. Results of operations research in family planning, Kinshasa, Zaire (19-21 July 1989): the role of operations research on family planning in Zaire. Summary. [Resultats de recherches operationnelles en naissances desirables, Kinshasa, Zaire (19-21 juillet 1989): le role de la recherche operationnelles dans les naissances desirables au Zaire. [Synthese]]
  55. Results of oral contraceptive epidemiologic studies regarding neoplastic and cardiovascular effects.
  56. Retention of contraceptive and AIDS information in the classroom.
  57. Retrieval of intrauterine contraceptive devices with missing tails, using Lamicel [letter]
  58. Return for follow-up care and contraceptive continuation among adolescents.
  59. A review of Planned Parenthood and women's development projects in selected family planning associations. Implications for the future.
  60. A review of recent epidemiologic studies on use of oral contraceptives and breast cancer.
  61. A review of the family planning program in the third stage of the Korean population transition.
  62. Revolving credit funds for women produce contraceptive use increases: interim report on a project in Indonesia.
  63. Rheumatoid arthritis and oral contraceptives in the Greek female population: a case-control study.
  64. Risk of contraceptive discontinuation among adolescents.
  65. The risks and benefits of oral contraceptives.
  66. The risks of oral contraceptives and estrogen replacement therapy.
  67. The role of community participation in improving the performace of family planning programmes.
  68. Role of contraception and development factors in fertility transition in the Asian region: a cross-country analysis.
  69. Role of contraception in birth spacing in Kerala.
  70. The role of family planning in maternal health and survival.
  71. The role of family planning in the prevention of maternal, infant and child mortality. [El papel de la planificacion familiar en la prevencion de la mortalidad materno-infantil.]
  72. The role of family planning programs as a fertility determinant.
  73. Role of incentive and compensation payments in family planning programs in Southern Asian countries: a background note.
  74. Role of incentives in the acceptance of family planning.
  75. The role of the Health Education Authority in family planning.
  76. RU-486: a new birth control option.
  77. Safety of Copper T as contraceptive after caesarean section.
  78. Scandinavian research in contraception, with a focus on developing countries. [Nordisk kontraceptionsforskning viktig for u-lander.]
  79. School-based clinic use and other factors affecting adolescent contraceptive behavior.
  80. Schooling, information and nonmarket productivity: contraceptive use and its effectiveness.
  81. In Search of a Rural Family Planning Service Delivery Model in Paraguay. Contract No. CI87.67A / CI89.06A, November 1, 1987 - August 31, 1989. Final technical report.
  82. Second quarterly report (April - June 1989): Social Marketing of Contraceptives Project, Pakistan.
  83. Self-esteem, spiritual well-being, and intimacy: a comparison among couples using NFP and oral contraceptives.
  84. Sero survey of human immunodeficiency virus infection in women at a family planning clinic: absence of infection in an indigent population in San Francisco.
  85. Serum copper levels in users of multiload intra-uterine contraceptive devices.
  86. Serum fructosamine and oral contraception.
  87. Serum glycocholic and glycochenodeoxycholic acids levels in triphasic pills users and injectable contraceptive users.
  88. Serum testosterone response to low dose dexamethasone and combined contraceptive pill in subgroups of patients with polycystic ovary syndrome.
  89. Service proximity as a determinant of contraceptive behavior: evidence from cross-national studies of survey data.
  90. Service vs survey statistics: an evaluation of contraceptive use in Pakistan.
  91. Sex education program in the outpatient family planning department of UNICAMP: its contribution to quality of care. [Programa de educacao sexual (PES), no ambulatorio de planejamento familiar da UNICAMP: sua contribuicao para a qualidade de atencao.]
  92. Sex, contraception and pregnancy among adolescents in foster care.
  93. Sex, contraception and pregnancy among adolescents in Mexico City.
  94. Sexual behavior and contraceptive risk taking among sexually active adolescent females.
  95. Sexual behavior and natural family planning teaching experiences.
  96. Sexual initiation and contraceptive practices in a group of young Limans. [Practicas de iniciacion sexual y anticoncepcion en un grupo de jovenes Limenos.]
  97. Sexual, reproductive and contraceptive risk factors for carcinoma-in-situ of the uterine cervix in Sydney.
  98. Sexually transmitted disease among women attending a family planning clinic in Zaria, Nigeria.
  99. Sexually transmitted diseases (STD) and contraception. [MST et contraception.]
  100. Sexually transmitted diseases and Chlamydia trachomatis in women consulting for contraception.
  101. Short term treatment of hirsutism related to micropolycystic ovary syndrome with a combination type oral contraceptive containing desogestrel.
  102. Should oral contraceptive use change in developing countries?
  103. Side effects of oral contraceptives in internal medicine -- a current problem. [Unerwunschte Wirkungen von oralen Kontrazeptiva im Bereich der Inneren Medizin - ein aktuelles Problem.]
  104. The simple analytics of contraceptive social marketing.
  105. A situation analysis of the family planning program of Kenya: the availability, functioning, and quality of MOH services.
  106. Small family--happy family: international population policy and family planning in India. [Small family--happy family: internationale Bevolkerungspolitik und Familienplanung in Indien.]
  107. Soap opera portrayals of sex, contraception, and sexually transmitted diseases.
  108. Social marketing of contraceptives with particular reference to condom use in Trinidad and Tobago.
  109. Social problems of contraception in the opinion of women from urban and rural areas. [Socjologiczne problemy antykoncepcji w opinii kobiet miasta i wsi.]
  110. Societal determinants of the regional differentials in India's family planning programme performance.
  111. Socio-cultural factors in modern family planning methods in Tanzania.
  112. Socio-cultural policies and programmes for efficient family planning in Africa.
  113. Sociodemographic determinants of contraceptive method choice in Sri Lanka: 1975-82.
  114. SOMARC and JHU/PCS assessment for a family planning project in Papua New Guinea, July 9 to August 1, 1989.
  115. Some metabolic and hormonal changes in women using long acting injectable contraceptives.
  116. States and societies: political aspects of population policy and family planning in developing countries, with special reference to China.
  117. Status of women and family planning: the Indian case.
  118. Sterilization reversal: issues and implications for voluntary surgical contraception.
  119. Strategic management in family planning: ideas and experiences. Overview.
  120. Strategic plan for the international programs of the Association for Voluntary Surgical Contraception, 1988 to 1992.
  121. Strategies for post-registration surveillance of contraceptive steroids.
  122. Strength of fertility motivation: its effects on contraceptive use in rural Sri Lanka.
  123. The strong connection between family planning and health. Contraceptive methods present and future. [Starkt samband familjeplanering -- halsa Kontraceptionsmetoder nu och i framtiden.]
  124. Structured stambayan to promote family planning in the Philippines: making productive use of idle time.
  125. A study of contraceptive drop-outs in Lesotho: using focus groups to determine causes of discontinuation.
  126. Study of family planning clientele served in different service organizations. [Estudio de la clientela de planificacion familiar atendida en diferentes organizaciones de servicio.]
  127. Study of rural leadership and implications for community participation and development in the health and family planning programs in Bangladesh.
  128. A study of the menopause, smoking, and contraception in women with Crohn's disease.
  129. A study of the use of model mothers as family planning motivators in a Thai rural village.
  130. A study on some organizational issues in community participation in the context of a national family planning programme: the case of Thailand.
  131. Success of the family planning programme in China.
  132. Summary of a meeting on Lessons Learned from Family Planning: How to Bring about Behavioral Change, July 26-27, 1989, Washington, DC. Pre-TAG Workshop, AIDSTECH / AIDSCOM.
  133. Summary of findings from research on family planning in the Gambia, 1984-1989.
  134. Summary of proceedings, Latin American conference on operations research: an approach to improve family planning services, November 7-10, 1988, Puerto Vallarta, Mexico.
  135. Summary: Conference on the Results of Operations Research on Family Planning in Zaire. [Resume: Conference sur les Resultats des Recherches Operationnelles en Naissances Desirables au Zaire.]
  136. Surgical contraception on mentally retarded women. [La esterilizacion quirurgica en mujeres con retardo mental.]
  137. Surgical contraception: new techniques and their possible reversibility. [Anticoncepcion quirurgica: nuevas tecnicas y su posible reversibilidad.]
  138. A survey of contraception in five West European countries.
  139. Survey of Fertility and Contraception INED-INSERM 1988: a presentation.
  140. A tale of three cities: mass media family planning promotion in Nigeria.
  141. Tanzania: family planning information, education, and communication needs assessment.
  142. Teaching inner-city mothers about family planning and prenatal and pediatric services.
  143. Teenagers' perceptions of unplanned adolescent pregnancies and oral contraceptive use.
  144. Test guideline for female barrier contraceptive devices.
  145. Testing the statutory coherence hypothesis. The implementation of federal family planning policy in the states.
  146. The TFR and birth control.
  147. Thinking about several problems of the research of our family planning strategy.
  148. The third medical Rwandan colloquium on the national family planning program. [Le troisieme colloque medical Rwandais sur le programme national de planification familiale.]
  149. To prescribe for the diabetic: a contraceptive method. [Prescrire chez la diabetique: une contraception.]
  150. Toward a framework for understanding contraceptive method choice.
  151. Toward a partnership for communication in family planning. Consensus-building seminar for decision makers. [Vers un partenariat pour la communication en matiere de planification familiale. Seminaire de recherche de consensus pour les decideurs.]
  152. Traditional contraception in Sri Lanka.
  153. Training manual for voluntary health workers in community-based health and family planning programmes.
  154. Training model in reproductive risk and family planning for health personnel. Operational experience in the application of a training model. [Modelo de capacitacion en riesgo reproductivo y planificacion familiar para los equipos de salud. Experiencia operativa en la aplicacion de un modelo de capacitacion.]
  155. Training model in reproductive risk and family planning for health personnel. The participatory process in the design and evaluation of training materials. [Modelo de capacitacion en riesgo reproductivo y planificacion familiar para los equipos de salud. El proceso participativo en el diseno y evaluacion de materiales de capacitacion.]
  156. Transdermal dual-controlled delivery of contraceptive drugs: formulation development, in vitro and in vivo evaluations, and clinical performance.
  157. Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use.
  158. The treatment of hyperandrogenism with oral contraceptives.
  159. Treatment of premenstrual syndrome with a triphasic oral contraceptive: a double-blind placebo-controlled trial.
  160. Trends and findings from the family planning operations research project in Zaire. [Directions et decouvertes du projet des recherches operationnelles en naissances desirables au Zaire.]
  161. Trends in contraceptive prevalence: are prevalence rates stagnating?
  162. Trial Regulations for strengthening family planning controls for the mobile population and individual entrepreneurs.
  163. Trip report, October 29 - November 21, 1989. Egypt Ministry of Health, Family Planning Systems Development Project, the Pathfinder Fund, SC QIN 470/CAW/MOH-01.
  164. Triphasic hormonal contraceptives. [Trifazni khormonalni kontratseptivi.]
  165. Tunisia and Morocco family planning programs: different approaches lead to similar outcomes.
  166. Tunisia Population and Family Planning Development Project semi-annual report, September 16, 1988 -March 15, 1989.
  167. An unfulfilled task. Issues of fertility, contraception and health-related problems in Ghana.
  168. Unmet need for contraception: a comparative study for Ghana, Lesotho and Sudan.
  169. Unmet need for family planning in Turkey.
  170. Unpopular contraceptives of the Indian family planning programme.
  171. Uptake of AIDS counselling and testing at a Scottish family planning clinic.
  172. Urban family planning toward self sufficiency in Indonesia.
  173. Use and knowledge of contraceptive methods in female students of early childhood education. [Uso y conocimiento de metodos anticonceptivos en mujeres estudiantes de educacion parvularia.]
  174. Use of a pilot test market to determine packaging and price levels for commercial contraceptives in Liberia.
  175. Use of clinic versus private family planning care by low-income women: access, cost, and patient satisfaction.
  176. Use of combined oral contraceptive preparations alters the insulin sensitivity of fatty acid and ketone metabolism.
  177. Use of contraceptive and related plants by the Kayapo Indians (Brazil)
  178. Use of family planning services.
  179. The use of periodic abstinence for family planning.
  180. USSR. Abortion and contraception.
  181. The utility of reproduction and economic measures for birth control.
  182. Vaginal douching in teenagers attending a family planning clinic.
  183. Vaginal infections in relationship to contraceptive usage.
  184. Validation of risk factors and detection of training needs. Operational evaluation of the application of the reproductive risk approach to the promotion and provision of family planning services. [Validacion de los factores de riesgo y deteccion de necesidades de capacitacion. Evaluacion operativa de la aplicacion del enfoque de riesgo reproductivo en la promocion y prestacion de servicios de planificacion familiar.]
  185. Validation of risk factors and detection of training needs. The information and communication process in the family planning program of the Instituto Mexicano del Seguro Social. [Validacion de los factores de riesgo y deteccion de necesidades de capacitacion. El proceso de informacion y comunicacion en el programa de planificacion familiar del Instituto Mexicano del Seguro Social.]
  186. The validity of different control groups in a case-control study. Oral contraceptive use and breast cancer in young women.
  187. Vascular risk of oral contraceptives. Reality and mechanism. 2. Mechanism of vascular accidents: their prevention. [Le risque vasculaire des contraceptifs oraux: realite et mecanisme. II. Mecanisme des accidents vasculaires: leur prevention.]
  188. The vascular risk of oral contraceptives: reality and mechanism. I. Risk evaluation. [Le risque vasculaire des contraceptifs oraux: realite et mecanisme. I. Evaluation du risque.]
  189. Vasectomy as a contraceptive method.
  190. Venous pathology and contraception. [Pathologie veineuse et contraception.]
  191. Venous pathology with combined estrogen-progestagen contraceptives. [Pathologie veineuse sous oestroprogestatifs.]
  192. Viet Nam. Knowledge and attitudes of grassroots family planning workers about contraceptive methods.
  193. Viet Nam: knowledge and attitudes of grassroots family planning workers about contraceptive methods.
  194. Vietnam's population and family planning programme.
  195. Virilizing granulosa cell tumor responsive to human chorionic gonadotropin and oral contraceptive with 8-year followup.
  196. Voluntary surgical contraception (VSC) in the Philippines (1989 follow-up survey of VSC acceptors in the Philippines)
  197. Wait a while, my love -- an Indonesian popular song with a family planning message.

     

  198. Watch out for the blue circle: a breakthrough in family planning promotional strategy.
  199. We must pay attention to the difference between the original intention and the current status of family planning.
  200. What can be expected of family planning? [Que peut-on attendre de la planification familiale?]
  201. What have we learned about utilization of contraceptives in Zaire]? [Que savons-nous sur l'utilisation des contraceptifs au Zaire.]
  202. What is best birth control to use after having a baby?
  203. What President Bush can do about family planning [editorial]
  204. When is chlamydia screening necessary in family planning?
  205. WHO guidelines on community based distribution of contraceptives in family planning programmes [draft]
  206. Why contraceptive prevalence estimates based on service statistics and sample surveys do not agree.
  207. Women and contraception in Mali. Individual will to practice in conflict with a pronatalist environment. [Femmes et contraception au Mali. La volonte individuelle de pratiquer en conflit avec un environnement pronataliste.]
  208. Women's behavior and knowledge concerning family planning in the region of the Park Health Center. [Park egitim saglik ocagi bolgesinde kadinlarin aile planlamasi konusundaki bilgi, tutum ve davranislari.]
  209. Women's opinion concerning methods of birth control. [Metody regulacji urodzen w opinii kobiet.]
  210. Women's roles and gender issues in family planning in Africa.
  211. Women's sex-role attitudes and contraceptive effectiveness.
  212. Women's soccer injuries in relation to the menstrual cycle and oral contraceptive use.
  213. World contraceptive use in 1987 [news]
  214. Young, low-parity women: critical target group for family planning in Bangladesh.
  215. Zambian population policy and the Integrated Family Planning Project.
  216. Comparative study of the acceptability of inert and copper-containing intrauterine contraceptive devices. [Sravnitelnoe izuchenie priemlemosti inertnykh i medsoderzhashchikh vnutrimatochnykh kontratseptivnykh sredstv.]
  217. Acceptability of injectable contraceptives in Assiut, Egypt.
  218. Analysis of contraceptive behavior of sexually active female adolescents in the United States.
  219. Assessment of a new low-dose once-a-month injectable contraceptive.
  220. The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use.
  221. Beliefs about contraceptive sterilization among low-income urban women.
  222. Birth control methods in the United States.
  223. Breast cancer and the pill -- a further report from the Royal College of General Practitioners' oral contraception study.
  224. Breast cancer in relation to early use of oral contraceptives: no evidence of a latent effect.
  225. Breast diseases (fibroadenomas, mastopathies, mammary carcinomas) and hormonal contraceptives. [Brustdrusenerkrankungen (Fibroadenome, Mastopathien, Mammakarzinome) unter hormonaler Kontrazeption.]
  226. Changes in contraceptive use and fertility: Panama, 1976 to 1984.
  227. The characteristics and prior contraceptive use of U.S. abortion patients.
  228. The completeness of cancer registration in England: an assessment from the Oxford-FPA contraceptive study.
  229. Contraception and the injecting opiate user.
  230. The contraceptive confidence idea: an empirical investigation.
  231. Contraceptive paths toward the reduction of unintended pregnancy and abortion.
  232. Contraceptive practice in New Zealand.
  233. Contraceptive side effects among current users in Thailand.
  234. Contraceptive social marketing and community-based distribution systems in Colombia.
  235. Contraceptive use and fertility in Costa Rica, 1986.
  236. Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. I. Regional variations.
  237. Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. II. The influence of individual characteristics.
  238. The effect of economic factors on contraceptive choice in Jamaica and Thailand: a comparison of mixed multinomial logit results.
  239. Effect of two oral contraceptives containing 30 micrograms ethinylestradiol and 75 micrograms gestodene or 150 micrograms desogestrel upon various hormonal parameters.
  240. Effects of hormonal contraceptives on breast milk composition and infant growth.
  241. Effects of oral estrogen-progestin contraceptives on blood coagulation and assessment of the risk of thromboembolism. [Effetti della contraccezione estro-progestinica orale sulla coagulazione plasmatica e valutazione del rischio tromboembolico.]
  242. Ethinyl oestradiol and d-norgestrel is an effective emergency postcoital contraceptive: a report of its use in 1,200 patients in a family planning clinic.
  243. Evidence that smoking alters prostacyclin formation and platelet aggregation in women who use oral contraceptives.
  244. Experiences with a sympto-thermal family planning method. [Erfahrungen mit einer sympto-thermalen Methode zur Familienplanung.]
  245. Family law and family planning in Colombia.
  246. Family planning clinics -- a story of growth and conflict.
  247. Family planning for teens: strategies for improving outreach and service delivery in public health settings.
  248. The family planning programmes of China and Thailand --a comparative study.
  249. Fertility and family planning among young adults in Jamaica.
  250. Fertility and family planning in China: an analysis of provincial patterns.
  251. First family planning visits by young women.
  252. Five-year, multicenter study of a triphasic, low-dose, combination oral contraceptive.
  253. Hormonal contraceptives and cardiovascular risks: results of a multicenter GDR case-control study. [Hormonale Kontrazeptiva und kardiovaskulares Risiko. Ergebnisse einer multizentrischen DDR-Fall-Kontroll-Studie.]
  254. Impact of a family planning and health services programme on adult female mortality.
  255. Impact of family planning on the health of children [editorial]
  256. Influence of low estrogen-containing oral contraceptives on lipoprotein phospholipid composition and mononuclear cell membrane fluidity.
  257. The influence of method of contraception and cigarette smoking on menstrual patterns.
  258. Influence of oral contraceptive treatment on blood pressure and 24-hour urinary catecholamine excretion in smoking as compared with non-smoking women.
  259. International experience with Norplant and Norplant-2 contraceptives.
  260. Intrauterine contraception in the case of a uterus bicornis after individual molding of the arms of the pessary. [Vutrematochna kontratseptsiia pri dvuroga matka sled individualno modelirane na ramenata na pesarite.]
  261. Is high dosage testosterone an effective male contraceptive agent?
  262. Labeling guidance for combination oral contraceptives. Physician labeling.
  263. The link between contraceptive methods and Chlamydia trachomatis infection.
  264. Lipid and lipoprotein changes associated with oral contraceptive use: a randomized clinical trial.
  265. Lipid and lipoprotein changes during the seven days off oral contraception in women using two triphasic preparations.
  266. Long-term use of an injectable contraceptive: effect of depot-norethisterone oenanthate on carbohydrate metabolism.
  267. Medical and contraceptive reasons for sterilization in the United States.
  268. Medical termination of pregnancy and concurrent contraceptive adoption in rural India.
  269. Metabolic changes in women using a long-acting monthly oral contraceptive and return of ovulation on discontinuation.
  270. Morphologic changes in the epithelium of the uterine cervix after longterm use of 19-norsteroid-containing oral hormonal contraceptives Non-Ovlon and Gravistat. [Morphologische Veranderungen am Epithel der Cervix uteri bei Langzeiteinnahme der 19-norsteroidhaltigen oralen hormonalen Kontrazeptiva Non-Ovlon und Gravistat.]
  271. A multicentre comparative study of serum lipids and lipoproteins in four groups of oral combined contraceptive users and a control group of IUD users.
  272. New insights on the mode of action of intrauterine contraceptive devices in women.
  273. Non-availability of the IUD and contraceptive choice.
  274. Norplant contraceptive subdermal implants: one year experience in Singapore.
  275. Oral contraceptive compliance in rural Colombia: knowledge of users and providers.
  276. Oral contraceptive use and malignancies of the genital tract: results from the Royal College of General Practitioners' Oral Contraception Study.
  277. Oral contraceptives and cervical cancer risk in Costa Rica. Detection bias or causal association?
  278. Oral contraceptives and gallstones [letter]
  279. Oral contraceptives and premenopausal breast cancer in nulliparous women.
  280. Oral contraceptives, sociocultural beliefs and psychiatric symptoms.
  281. Participation in child health and family planning activities in rural Southern Ghana.
  282. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use.
  283. Personality profiles and socioeconomic factors in contraceptive use.
  284. The politics of birth control.
  285. Population and family planning: an international perspective.
  286. Post-coital contraception--a two year evaluation of a service.
  287. Prevalence of contraceptive use: trends and issues.
  288. The prevalence of positive test results for Chlamydia trachomatis by direct smear for fluorescent antibodies in a South Texas family planning population.
  289. Problem visits to a family planning clinic.
  290. Prospective studies of insulin sensitivity in normal women receiving oral contraceptive agents.
  291. A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases.
  292. Public funding of family planning, sterilization and abortion services, 1987.
  293. Response of a traditional fishing community to China's family planning program: a case study.
  294. The roles of individuals' socioeconomic characteristics and the government family planning program in China's fertility decline.
  295. Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives.
  296. Suppression of ovulation in women using a triphasic oral contraceptive.
  297. A survey of prescribing habits for high-estrogen oral contraceptives.
  298. Thyroid disorders and oral contraceptives.
  299. Title X and family planning services for men.
  300. U.S. women's contraceptive attitudes and practice: how have they changed in the 1980s?
  301. Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception.
  302. Young adults in Latin America and the Caribbean: their sexual experience and contraceptive use.
  303. China. Knowledge and attitudes of grassroots family planning workers about contraceptive methods.
  304. China: knowledge and attitudes of grassroots family planning workers about contraceptive methods.
  305. Chlamydia trachomatis genital infections and contraception. [Infezioni genitali da Chlamydia trachomatis e contraccezione.]
  306. Choice of contraceptives.
  307. Choosing a contraceptive method: why does it matter?
  308. Choosing an oral contraceptive.
  309. Chorea as the initial presentation of oral contraceptive induced systemic lupus erythematosus [letter]
  310. Circular on family planning, 1988.
  311. Clinical evaluation of a monophasic ethinylestradiol / desogestrel-containing oral contraceptive.
  312. Clinical experience in Switzerland with the new monophasic oral contraceptive Minulet (75 mcg gestodene, 30 mcg ethinyl oestradiol)
  313. Clinical experience with intrauterine contraceptive devices (IUDs) inserted with and without tail.
  314. Clinical results of a new contraceptive intra-uterine device: Ombrelle 250.
  315. A clinical study on the contraceptive effect of vaginal application of levonorgestrel.
  316. Clinical trial of a post-coital contraceptive pill.
  317. Cognitive analysis of contraceptive behavior.
  318. Coitus-dependent contraceptives: factors associated with effective use.
  319. Colombia: Third National Contraceptive Prevalence Survey and First Demographic and Health Survey. 1986. [Colombia: Tercera Encuesta Nacional de Prevalencia del Uso de Anticonceptivos y Primera de Demografia y Salud. 1986.]
  320. Colombians turning to men for birth control.
  321. Combined estrogen-progestagen contraception and glucid and water-sodium metabolism. [Contraception estroprogestative et metabolisme glucidique et hydrosode.]
  322. Combining research techniques in the study of fertility and family planning in Java: theory and practice.
  323. Commercial movies and TV-programs: a new strategy to promote family planning in Mexico.
  324. Communication in the social marketing of contraceptives: a case study of the Bangladesh project.
  325. Communication strategies in family planning: lessons learned from the African experience favoring a systematic approach. [La communication pour le bien-etre familial: lecons a tirer de l'experience Africaine favorisant une approche systematique.]
  326. Community characteristics, leaders, fertility and contraception in Bangladesh.
  327. Community development and family planning: an Egyptian experiment.
  328. Community participation in family planning: a case study of the Family Welfare Centre Project, Pakistan.
  329. Community participation in family planning: a case study of the Kundam Family Welfare Project, India.
  330. Community participation in family planning: case studies from Nepal.
  331. Community-based contraceptive distribution programme of Family Planning Association of India and Banaras Hindu University.
  332. Community-level effects of village contraceptive distribution centers on the institutionalization of the small family norm in Indonesia.
  333. A comparative analysis of community participation projects in South Asia with policy and programme recommendations for family planning associations.
  334. Comparative effects of combined oral contraceptives containing desogestrel or levonorgestrel on serum lipids, lipoproteins and sex hormone binding globulin in healthy women.
  335. A comparative study of the ease of removal of intrauterine contraceptive devices.
  336. Comparative trial of the effects on glucose tolerance and lipoprotein metabolism of two new oral contraceptives containing gestoden and desogestrel.
  337. The 14th Jennifer Hallam Memorial Lecture, present and future trends in contraception.
  338. 42 month progress report: continuation and expansion of family planning operations research in Zaire.
  339. Abortion and contraception, 1985-1986: yearly reports from the abortion register, and information from various surveys concerning contraceptive practice in the Netherlands. [Abortus en anticonceptie, 1985/86: jaarverslag van de abortusregistratie, aangevuld met diverse onderzoeksgegevens betreffende anticonceptiegebruik in Nederland.]
  340. Abortions among Israeli women after interruption in contraceptive use.
  341. Abortions, contraceptive use and locus of control.
  342. Abstinence, sexuality, and natural family planning.
  343. Acceptability of hormonal contraceptives with a low steroid content. [Priemlemost gormonalnykh kontratseptivov s nizkim soderzhaniem steroidov.]
  344. Access to birth control: a world estimate. [Acceso al control de la natalidad: un estimativo mundial.]
  345. Access to family planning in Latin America.
  346. Achieved fertility, family size desires and contraceptive use.
  347. Acitretin (RO10-1670) and oral contraceptives: interaction study.
  348. Acne: long-term therapy with side effect. Sebaceous gland activity is androgen dependent -- acne therapeutic drug is effective as a contraceptive. [Akne: Langzeittherapie mit Nebeneffekt. Talgdrusenaktivitat androgenabhangig -- Aknetherapeutikum auch kontrazeptiv wirksam.]
  349. An Act (No. 72 of 1987) to prescribe the law in relation to the sale of condoms and related matters and to repeal the Police Offences (Contraceptives) Act 1941 and the Police Offences (Contraceptives) Repeal Act 1976. Date of assent: 27 November 1987. (The Sale of Condoms Act 1987)
  350. The action of contraceptive hormones on the liver: clinical and experimental results. [Zur Wirkung kontrazeptiver Hormone auf die Leber -- klinische und experimentelle Ergebnisse.]
  351. Administration of Itinerant Population Family Planning Procedures, 1988.
  352. Adolescence and contraception. [Adolescencia y anticoncepcion.]
  353. Adolescent contraception.
  354. Adolescent contraception: an overview.
  355. Adolescent contraception: an overview.
  356. Adolescent contraceptive blockade. [Bloqueo anticoncepcional juvenil.]
  357. Adolescent decision-making and contraceptive behavior: final report.
  358. Adolescent males' sexual behavior and contraceptive use: implications for male responsibility.
  359. Advances in voluntary surgical contraception.
  360. The advantages of minilaparotomy as a contraceptive in family planning. [Les avantages de minilaparatomie comme une methode de planning familial.]
  361. Advice on contraceptive services for ethnic minorities [letter]
  362. Africa: a new frontier in family planning: lessons learned from operations research.
  363. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
  364. Age, metabolism and oral contraception.
  365. AIDS and contraception. [Sida et contraception.]
  366. AIDS and family planning facts for the general public.
  367. AIDS and family planning programmes.
  368. AIDS and family planning.
  369. AIDS and family planning. [Le SIDA et le bien-etre familial.]
  370. AIDS conference stresses family planning role.
  371. AIDS in Africa: the role of U.S. based family planning training organizations in containing the epidemic.
  372. AIDS risk estimate may help you answer family planning questions.
  373. AIDS: family planning workers join the battle.
  374. AIDS: model curriculum for family planning nurses and midwives. [SIDA: modulo curricular para enfermeras y obstetrices de planificacion familiar.]
  375. All-Union Scientific-Applied Conference "Family Planning and National Traditions" (Tbilisi, November 28-30, 1988). Abstracts of papers. [Vsesoyuznaya nauchno-prakticheskaya konferentsiya "Planirovanie Sem'i i Natsional'nye Traditsii" (g. Tbilisi, 28-30 noyabrya 1988 goda). Tezisy dokladov.]
  376. Alprazolam pharmacokinetics in women on low-dose oral contraceptives.
  377. Alternate delivery systems for contraceptive progestogens.
  378. American attitudes to international family planning and population issues. A survey conducted for: the Population Crisis Committee and the Planned Parenthood Federation of America.
  379. Analysis of a representative sample of natural family planning users in England and Wales, 1984-1985.
  380. Analysis of oral contraceptive risks.
  381. An analysis of the empirical relationship between contraceptive prevalence and fertility in Bangladesh.
  382. Anchored IUDs. A new development in intrauterine contraception.
  383. Andean Seminar on Family Planning Research and Services. [Seminario Andino de Investigacion y Servicios de Planificacion Familiar.]
  384. Annual report of the Sarawak Family Planning Association (a voluntary organisation). 1987.
  385. Antiprogestins -- the possibility of a new type of contraceptives. [Antiprogestinite--vuzmozhnost za nov vid kontratseptivi.]
  386. Application of anti-progesterone agents for contraception.
  387. Approval of a new oral contraceptive, 1988.
  388. Are Latin American and Caribbean men irresponsible with regard to family planning? A surprising male view.
  389. Are Latin American and Caribbean men irresponsible with regard to family planning? An inaccurate view of Caribbean men.
  390. Are Latin American and Caribbean men irresponsible with regard to family planning? It is the couple who gets pregnant.
  391. Aryl 4-guanidinobenzoates: potential vaginal contraceptives.
  392. Assessing the fertility impact of quality of family planning services.
  393. Assessing the need for contraception in Sub-Saharan Africa: 1987 to 2025.
  394. Assessment of barriers to vasectomy in Honduras and implementation of strategies to increase demand for voluntary male surgical contraception. Phase I, ASHONPLAFA -- AVSC. Final Report. Draft.
  395. Assessment of reimbursement mechanism and cost analysis of voluntary surgical contraception. Final Report. Draft.
  396. Associations of parity, breast-feeding, and birth control pills with lumbar spine and femoral neck bone densities.
  397. At risk aspects of metabolic effects of oral contraceptives.
  398. The attitude of women toward planned parenthood and contraception. [Postoje zen k planovanemu rodicovstvi a antikoncepci.]
  399. Attitude toward and use of contraceptives among sexually active black adolescent males.
  400. Attitudes of urban Sudanese men toward family planning.
  401. Attitudes toward sex, arousal, and the retention of contraceptive information.
  402. Audiovisual materials for family planning programs.
  403. The availability of contraception.
  404. The availability of data to assess family planning programs in Sub-Saharan Africa.
  405. Aziza Hussein. Family law and family planning in Egypt.
  406. Barrier contraceptives.

     

  407. Barrier methods: contraception and STD prophylaxis.
  408. Becoming pregnant, knowledge, attitude and practice of contraception in the school and university environment. [Devenir des grossesses, connaissances, attitudes et pratique de la contraception en milieu scolaire et universitaire.]
  409. Behaviour and attitudes concerning family planning in Italy.
  410. A benefit-cost analysis of family planning services in Iowa.
  411. Benefits and costs of providing family planning services: the thirty year experience of Tata Iron and Steel Company, Jamshedpur, India.
  412. Benefits and risks of oral contraceptives.
  413. Beyond contraception: the health benefits and risks of the pill.
  414. Beyond supply: the importance of female family planning workers in rural Bangladesh.
  415. Bilateral ileofemoral thrombophlebitis after ten contraceptive pills in a 25-year-old woman with antithrombin III deficiency.
  416. The biological effects of oral contraceptives.
  417. Birth control devices: Monsanto gets one-two punch.
  418. Birth control in Britain during the interwar years: evidence from the Stopes correspondence.
  419. Birth control in Germany, 1871-1933.
  420. Birth control in the early stage of marriage. [Regulacja urodzen w poczatkowym okresie malzenstwa.]
  421. Birth control vaccine against human chorionic gonadotrophin.
  422. Birth control vaccine [letter]
  423. Birth control vaccines inducing antibodies against chorionic gonadotropin.
  424. Birth control vaccines.
  425. Birth order distribution as a family planning program evaluation indicator.
  426. Blood testing before prescribing oral contraception in Africa [letter]
  427. The Bolivian national family planning communication campaign: results of the final evaluation.
  428. Breast-feeding and natural family planning.
  429. Breastfeeding as a family planning method. Consensus statement. [Report]
  430. Breastfeeding promotion in family planning programs.
  431. Bulletin of major figures from manual tabulation of the national sample survey on fertility and birth control of China.
  432. Cameroon. Population: family planning.
  433. Cancer risk in connection with oral contraceptives and postmenopausal hormone treatment. [Cancerrisk i samband med p-pillerintag och postmenopausal hormonbehandling.]
  434. Candidiasis in women fitted with an intrauterine contraceptive device [letter]
  435. Candidiasis in women fitted with an intrauterine contraceptive device.
  436. Candidiasis in women fitted with an intrauterine contraceptive device. Author's reply [letter]
  437. Carbohydrate and lipid metabolism in users of fixed-dose, combined oral contraceptives containing levonorgestrel or desogestrel.
  438. A case of extensive myocardial infarction in a young woman as a complication of oral contraceptives and alcohol. [Przypadek rozleglego zawalu serca u mlodej kobiety jako powiklanie po doustnych srodkach antykoncepcyjnych i alkoholu.]
  439. A case study of contraceptive introduction: domiciliary DMPA services in rural Bangladesh.
  440. A case-control study of breast cancer in relation to oral contraceptive use in Slovenia.
  441. Cash payments to encourage contraception, 1988.
  442. The Catholic church and family planning. [L'eglise Catholique et le bien-etre familial.]
  443. Cervical cap approved for contraception.
  444. Chad's concept of family planning. [Concept du bien-etre familial au Tchad.]
  445. Changes in plasma levels of androgens and SHBG in patients with polycystic ovary syndrome (PCOs) treated with oral contraceptives containing desogestrel. [Modificazione dei livelli plasmatici degli androgeni e della SHBG in pazienti con sindrome dell'ovaio policistico (PCOs) trattate con contraccettivi orali contenenti desogestrel.]
  446. Changes in pure-tone thresholds and temporary threshold shifts as a function of menstrual cycle and oral contraceptives.
  447. Changes in the plasma levels of vitamin K-dependent proteins C and S and of C4b-binding protein during pregnancy and oral contraception.
  448. The characteristics of and the contraceptive practice among women seeking therapeutic termination of pregnancy in the Scottish highlands.
  449. Chiclayo, Peru: sexuality and family planning in women of different socioeconomic status. [Chiclayo, Peru: sexualidad y planificacion familiar en mujeres de diferente condicion socioeconomica.]
  450. China's population policy and family planning programme.
  451. Comparing family planning methods.
  452. A comparison of the effects of two triphasic oral contraceptives on haemostasis.
  453. Compendium of concepts relative to population policies, birth control, family planning, responsible parenthood, sex education, contraception. [Recopilacion de conceptos relativos a: politicas de poblacion, control de la natalidad, planificacion familiar, paternidad responsable, educacion sexual, anticoncepcion.]
  454. Complications of oral contraceptives and antiphospholipid antibodies: reply to the letter by Bruneau et al [letter]
  455. Components of family planning in rural Egypt.
  456. Conception and birth control use: Cambodian refugee women's beliefs and practices.
  457. Condoms: the contraceptive whose time has come -- again.
  458. Condyloma and contraception: the influence of contraception on the evolution of cervical lesions caused by papillomavirus. [Condylome et contraception: influence de la contraception sur l'evolution des lesions du col uterin par papillomavirus.]
  459. Congenital limb reduction deformities and oral contraceptives [letter]
  460. Congenital limb reduction deformities and oral contraceptives, letter] Reply.
  461. Consequences of uterine blood loss caused by various intrauterine contraceptive devices in South American women.
  462. Constraints to family planning promotion in Tanzania.
  463. The construction of the fertility model of variable parity from family planning practice.
  464. A consumer intercept study of oral contraceptive users in the Dominican Republic.
  465. Consumer perceptions of family planning.
  466. Contemporary issues in family planning.
  467. Continuation and effectiveness of program and non-program methods of family planning in rural Sri Lanka.
  468. Continuation and expansion of family planning operations research in Zaire: 48 months progress report and workplan for year V: October 1988 to September 1989.
  469. Contraception after childbirth in Thailand.
  470. Contraception among women demanding abortion. [Prevensjonsbruk blant abortsokende kvinner.]
  471. Contraception and contraceptive methods. [Anticoncepcion y metodos anticonceptivos.]
  472. Contraception and ectopic pregnancy.
  473. Contraception and informed choice in the United States: a review of literature.
  474. Contraception and reproduction in women with changes of the cervix uteri and suspicious results of cytologic and colposcopic examination. [Antykoncepcja i rozrod u kobiet ze zmianami szyjki macicy z podejrzanymi wynikami badan cytologiczno-kolposkopowych.]
  475. Contraception and society.
  476. Contraception and the family life cycle. [Contraception et cycle de vie familiale.]
  477. Contraception at 40 years of age. [La contraception a 40 ans.]
  478. Contraception by age group.
  479. Contraception during breastfeeding: a clinician's sourcebook.
  480. Contraception for adolescents -- information for pediatricians. [Antikoncepce pro mladistve -- informace pro pediatry.]
  481. Contraception for adolescents.
  482. Contraception for adolescents: methods and modes of action. [Contraception des adolescentes: methodes et modes d'action.]
  483. Contraception for the diabetic woman. [Contraception chez la femme diabetique.]
  484. Contraception for the woman aged 35 yr and over.
  485. Contraception for women exposed in utero to diethylstilbestrol.
  486. Contraception for women over the age of 35.
  487. Contraception in adolescence. [Anticoncepcion en la adolescencia.]
  488. Contraception in adolescents. [Kontrazeption bei Jugendlichen.]
  489. Contraception in adolescents. Taking responsibility and indications. [La contraception de l'adolescente. Prise en charge et indications.]
  490. Contraception in females with chronic salpingoophoritis during autoblood UV-radiation.
  491. Contraception in France: pill and IUD. [La contraception en France: pilule et sterilet.]
  492. Contraception in the male.
  493. Contraception in women with ileostomies. [Schwangerschaftsverhutung bei Ileostomietragerinnen.]
  494. Contraception in women with systemic lupus erythematosus. [Contraception chez la femme lupique.]
  495. Contraception not a matter for free theological discussion.
  496. Contraception research for today and the nineties: progress in birth control vaccines.
  497. Contraception with microdose progestational hormones. [Contraception par progestatifs microdoses.]
  498. Contraception with Norplant implants and Norplant-2 implants (two covered rods). Results from a comparative clinical study in Sweden.
  499. Contraception with the diaphragm: a 2-year follow-up study.
  500. Contraception.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info